We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$14.7B
AUM Growth
-$1.86B
Cap. Flow
-$3.45B
Cap. Flow %
-23.47%
Top 10 Hldgs %
17.8%
Holding
2,719
New
551
Increased
717
Reduced
671
Closed
743

Top Buys

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$94.7M
2
ARKB icon
ARK 21Shares Bitcoin ETF
ARKB
+$84.4M
3
CSX icon
CSX Corp
CSX
+$76.5M
4
NVDA icon
NVIDIA
NVDA
+$75.4M
5
TSM icon
TSMC
TSM
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 14.97%
2 Industrials 14.38%
3 Financials 9.36%
4 Consumer Discretionary 8.94%
5 Healthcare 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLS icon
2101
Celestica
CLS
$37.1B
-47,903
Closed -$3.78M
CMA
2102
DELISTED
Comerica
CMA
-20,402
Closed -$1.2M
CNA icon
2103
CNA Financial
CNA
$13.4B
-57,200
Closed -$2.91M
CNP icon
2104
CenterPoint Energy
CNP
$25.8B
-15,274
Closed -$553K
COGT icon
2105
Cogent Biosciences
COGT
$6.29B
-10,080
Closed -$60.4K
COLM icon
2106
Columbia Sportswear
COLM
$3.08B
-16,891
Closed -$1.28M
CORT icon
2107
Corcept Therapeutics
CORT
$13.3B
-100
Closed -$11.4K
CORT icon
2108
PUT
Corcept Therapeutics
CORT
$13.3B
-80,000
Closed -$9.14M
CP icon
2109
Canadian Pacific Kansas City
CP
$83.2B
-33,881
Closed -$2.38M
CPIX icon
2110
Cumberland Pharmaceuticals
CPIX
$117M
-17,900
Closed -$75.7K
CPRX
2111
DELISTED
Catalyst Pharmaceutical
CPRX
-97,529
Closed -$2.37M
CPRI icon
2112
CALL
Capri Holdings
CPRI
$1.55B
-45,000
Closed -$888K
CRGY icon
2113
Crescent Energy
CRGY
$4.58B
-15,734
Closed -$177K
CRWD icon
2114
CrowdStrike
CRWD
$194B
-9,372
Closed -$1.02M
CRWD icon
2115
PUT
CrowdStrike
CRWD
$194B
-90,000
Closed -$7.93M
CRVS icon
2116
Corvus Pharmaceuticals
CRVS
$1.19B
-39,783
Closed -$127K
CSAN icon
2117
Cosan
CSAN
$2.64B
-40,600
Closed -$212K
CSL icon
2118
Carlisle Companies
CSL
$14.4B
-1,361
Closed -$463K
CSW
2119
CSW Industrials
CSW
$5.34B
-3,813
Closed -$1.11M
CTAS icon
2120
PUT
Cintas
CTAS
$83B
-15,000
Closed -$3.08M
CTMX icon
2121
CytomX Therapeutics
CTMX
$717M
-589,332
Closed -$375K
CTO
2122
CTO Realty Growth
CTO
$825M
-107,800
Closed -$2.08M
CTRA
2123
DELISTED
Coterra Energy
CTRA
-9,787
Closed -$283K
CUK
2124
DELISTED
Carnival PLC
CUK
-26,348
Closed -$462K
CVBF icon
2125
CVB Financial
CVBF
$3.95B
-14,540
Closed -$268K

Similar funds

Steve Schonfeld's Q2 2025 Portfolio in Review

As of Q2 2025, Steve Schonfeld held 2,719 positions worth $14.7B, down 11% from $16.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Steve Schonfeld withdrew a net $3.45B in Q2 2025, closing 743 positions and reducing 671 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $2.42B position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Steve Schonfeld opened a new position in James Hardie Industries worth $60.6M.

  • Steve Schonfeld's largest Q2 2025 buy was James Hardie Industries: 2,253,452 shares worth $60.6M.
  • Steve Schonfeld added most to Caterpillar in Q2 2025, an estimated $94.7M increase.
  • Steve Schonfeld's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $483M.
  • Steve Schonfeld fully exited iShares Core S&P 500 ETF in Q2 2025, selling an estimated $2.42B.
  • Steve Schonfeld's ten largest holdings make up 18% of its $14.7B portfolio in Q2 2025.
  • Steve Schonfeld opened 551 new positions and closed 743 in Q2 2025.
  • Steve Schonfeld's portfolio value fell 11% quarter-over-quarter to $14.7B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.